CHA News Article

Drug Enforcement Administration Discusses IV Opioid Shortage With California Hospitals

During CHA’s Congressional Action Program in Washington, D.C. earlier this month, Sen. Dianne Feinstein expressed a deep concern over the continuing intravenous opioid shortage as well as a strong interest in finding a quick solution.

To illustrate the issue, CHA developed an online survey that allowed hospitals to describe the direct effect of the shortage. CHA thanks the 194 hospitals that responded to the survey, as their insight has been key in demonstrating the shortage’s impact on patients and communities.

Sen. Feinstein’s staff has continued to be actively engaged with the Drug Enforcement Administration (DEA) on this issue and facilitated a call between the DEA and CHA to hear directly from California hospitals. During the call, the survey results were reviewed and hospital leaders shared firsthand how the shortage continues to impact clinical care.